Related Experiment Video
Updated: Jul 19, 2026
10:03
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Alpha-synuclein enhances dopamine D2 receptor signaling.
Sung Jae Kim1, Sung Yul Kim, Young-Soon Na
1Molecular Neurobiology Laboratory, School of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Korea.
Brain Research
|November 8, 2006
Summary
Alpha-synuclein enhances dopamine D2 receptor signaling, impacting intracellular pathways. This finding offers a potential mechanism for synaptic homeostasis in Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
Area of Science:
- Neuroscience
- Molecular Biology
- Neurodegenerative Diseases
Background:
- Parkinson's disease (PD) involves dopamine neuron loss in the substantia nigra (SN), leading to striatal dopamine depletion and Lewy bodies (LBs).
- Alpha-synuclein aggregation in LBs is implicated in PD and dementia with LBs (DLB), with mutations linked to familial PD.
- The precise mechanism by which alpha-synuclein contributes to neurodegeneration remains incompletely understood.
Purpose of the Study:
- To investigate the effect of alpha-synuclein on the downstream signaling of the dopamine D2 receptor (D2R).
- To elucidate the role of alpha-synuclein in modulating D2R-mediated intracellular pathways.
Main Methods:
- Utilized Chinese Hamster Ovary (CHO) cells stably transfected with D2Rs.
- Assessed the impact of alpha-synuclein on D2-agonist-mediated inhibition of adenylate cyclase activity.
- Examined the effect on downstream cAMP-responsive element (CRE)-mediated gene transcription.
Main Results:
- Alpha-synuclein significantly enhanced the D2-agonist-mediated inhibition of adenylate cyclase in D2R-expressing CHO cells.
- This enhancement by alpha-synuclein consequently affected downstream CRE-mediated gene transcription.
- A C-terminal deletion mutant of alpha-synuclein did not exhibit the same enhancing effect, suggesting the C-terminus is important.
Conclusions:
- Alpha-synuclein potentiates dopamine-mediated intracellular signaling pathways via the D2 receptor.
- This interaction provides a potential molecular mechanism for alpha-synuclein's role in presynaptic regulation.
- The findings suggest a novel pathway contributing to synaptic homeostasis in dopaminergic neurotransmission relevant to PD and DLB.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...